Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.10
NAS:MLAB's Cash to Debt is ranked lower than
90% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. NAS:MLAB: 0.10 )
Ranked among companies with meaningful Cash to Debt only.
NAS:MLAB' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: No Debt Max: No Debt
Current: 0.1
Equity to Asset 0.54
NAS:MLAB's Equity to Asset is ranked lower than
57% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. NAS:MLAB: 0.54 )
Ranked among companies with meaningful Equity to Asset only.
NAS:MLAB' s Equity to Asset Range Over the Past 10 Years
Min: 0.51  Med: 0.93 Max: 0.97
Current: 0.54
0.51
0.97
Interest Coverage N/A
NAS:MLAB's Interest Coverage is ranked higher than
76% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.77 vs. NAS:MLAB: N/A )
Ranked among companies with meaningful Interest Coverage only.
NAS:MLAB' s Interest Coverage Range Over the Past 10 Years
Min: N/A  Med: 9999.5 Max: No Debt
Current: N/A
N/A
No Debt
F-Score: 4
Z-Score: 4.98
M-Score: -2.27
WACC vs ROIC
4.62%
9.95%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 18.02
NAS:MLAB's Operating margin (%) is ranked higher than
86% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.89 vs. NAS:MLAB: 18.02 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:MLAB' s Operating margin (%) Range Over the Past 10 Years
Min: 18.02  Med: 30.77 Max: 36.1
Current: 18.02
18.02
36.1
Net-margin (%) 12.63
NAS:MLAB's Net-margin (%) is ranked higher than
82% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. NAS:MLAB: 12.63 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:MLAB' s Net-margin (%) Range Over the Past 10 Years
Min: 12.63  Med: 19.42 Max: 23.57
Current: 12.63
12.63
23.57
ROE (%) 13.50
NAS:MLAB's ROE (%) is ranked higher than
77% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. NAS:MLAB: 13.50 )
Ranked among companies with meaningful ROE (%) only.
NAS:MLAB' s ROE (%) Range Over the Past 10 Years
Min: 13.5  Med: 17.89 Max: 22.21
Current: 13.5
13.5
22.21
ROA (%) 7.12
NAS:MLAB's ROA (%) is ranked higher than
74% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.61 vs. NAS:MLAB: 7.12 )
Ranked among companies with meaningful ROA (%) only.
NAS:MLAB' s ROA (%) Range Over the Past 10 Years
Min: 7.12  Med: 14.85 Max: 20.4
Current: 7.12
7.12
20.4
ROC (Joel Greenblatt) (%) 58.16
NAS:MLAB's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.16 vs. NAS:MLAB: 58.16 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:MLAB' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 58.16  Med: 69.89 Max: 80.91
Current: 58.16
58.16
80.91
Revenue Growth (3Y)(%) 20.40
NAS:MLAB's Revenue Growth (3Y)(%) is ranked higher than
89% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. NAS:MLAB: 20.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:MLAB' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 6  Med: 14 Max: 24.7
Current: 20.4
6
24.7
EBITDA Growth (3Y)(%) 10.80
NAS:MLAB's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. NAS:MLAB: 10.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NAS:MLAB' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 3.9  Med: 11 Max: 27.9
Current: 10.8
3.9
27.9
EPS Growth (3Y)(%) 8.10
NAS:MLAB's EPS Growth (3Y)(%) is ranked higher than
56% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. NAS:MLAB: 8.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:MLAB' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 4.7  Med: 9.7 Max: 24
Current: 8.1
4.7
24
» NAS:MLAB's 10-Y Financials

Financials (Next Earnings Date: Est. 2017-02-02)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

MLAB Guru Trades in Q4 2015

Jim Simons 138,599 sh (+3.12%)
Chuck Royce 44,500 sh (-9.72%)
» More
Q1 2016

MLAB Guru Trades in Q1 2016

Chuck Royce 59,100 sh (+32.81%)
Jim Simons 136,400 sh (-1.59%)
» More
Q2 2016

MLAB Guru Trades in Q2 2016

Chuck Royce 54,000 sh (-8.63%)
Jim Simons 101,600 sh (-25.51%)
» More
Q3 2016

MLAB Guru Trades in Q3 2016

Jim Simons 94,159 sh (-7.32%)
Chuck Royce 40,300 sh (-25.37%)
» More
» Details

Insider Trades

Latest Guru Trades with MLAB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:OSUR, AMEX:CRHM, NAS:LMAT, NAS:STAA, NAS:CFMS, OTCPK:GMDTF, NAS:ENTL, NAS:ANGO, NAS:ELGX, NAS:ATRC, NAS:ATRS, NAS:UTMD, OTCPK:NNCSF, NAS:NVCR, AMEX:TRXC, NAS:SIEN, NAS:DSCI, NAS:BIOL, AMEX:BVX, NAS:IVTY » details
Mesa Laboratories Inc designs, manufactures and markets quality control instruments and disposable products and also manufactures and markets biological indicators and distributes chemical indicators.

Mesa Laboratories Inc was incorporated under the laws of the State of Colorado on March 26, 1982. The Company is focused on quality control products, which are sold into niche markets that are driven by regulatory requirements. It is organized into three divisions across six physical locations. Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling and semiconductor industries. Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. Continuous Monitoring Division designs, develops and markets systems which are used to monitor various environmental parameters such as temperature, humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies and a number of other laboratory and industrial environments. The Lakewood, Colorado, and Butler, New Jersey, facilities manufacture Instruments Division products which include the DataTrace, DialyGuard, DryCal, Torqo, SureTorque and BGI brands. The Omaha, Nebraska, and Bozeman, Montana locations manufacture Biological Indicators Division products which include the Mesa, PCD and Apex brands, while the Lakewood, Colorado, facility also manufactures Continuous Monitoring Division products which include CheckPoint and AmegaView brands. Companies with which Instruments Division products compete include the Myron L Company, IBP Medical GmbH, Amphenol Corporation, Ellab, TMI Orion, Danaher, Inc., Thermo Fisher Scientific, Inc., Mecmesin, Steinfurth, Met One Instruments, Inc. and Tisch Environmental. Biological Indicators Division products compete with 3M, Terragene, NAMSA and Steris, among others. Continuous Monitoring Division systems compete with Rees Scientific Corporation, Amphenol Corporation and Cooper-Atkins, among others. Several products in both the Instruments and Biological Indicators Divisions are medical devices subject to the provisions of the Federal Food, Drug and Cosmetic Act, as amended by the Medical Device Amendments of 1976.

Ratios

vs
industry
vs
history
P/E(ttm) 42.91
MLAB's P/E(ttm) is ranked lower than
73% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.20 vs. MLAB: 42.91 )
Ranked among companies with meaningful P/E(ttm) only.
MLAB' s P/E(ttm) Range Over the Past 10 Years
Min: 10.41  Med: 18.84 Max: 45.47
Current: 42.91
10.41
45.47
PE(NRI) 42.91
MLAB's PE(NRI) is ranked lower than
75% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.71 vs. MLAB: 42.91 )
Ranked among companies with meaningful PE(NRI) only.
MLAB' s PE(NRI) Range Over the Past 10 Years
Min: 10.41  Med: 18.84 Max: 45.47
Current: 42.91
10.41
45.47
Price/Owner Earnings (ttm) 167.19
MLAB's Price/Owner Earnings (ttm) is ranked lower than
93% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.97 vs. MLAB: 167.19 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
MLAB' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 12.55  Med: 19.91 Max: 171.43
Current: 167.19
12.55
171.43
P/B 5.29
MLAB's P/B is ranked lower than
70% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. MLAB: 5.29 )
Ranked among companies with meaningful P/B only.
MLAB' s P/B Range Over the Past 10 Years
Min: 1.78  Med: 3.22 Max: 5.53
Current: 5.29
1.78
5.53
P/S 5.45
MLAB's P/S is ranked lower than
72% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. MLAB: 5.45 )
Ranked among companies with meaningful P/S only.
MLAB' s P/S Range Over the Past 10 Years
Min: 2.32  Med: 3.93 Max: 6.77
Current: 5.45
2.32
6.77
PFCF 64541.84
MLAB's PFCF is ranked lower than
100% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.13 vs. MLAB: 64541.84 )
Ranked among companies with meaningful PFCF only.
MLAB' s PFCF Range Over the Past 10 Years
Min: 12.39  Med: 26.38 Max: 66176.87
Current: 64541.84
12.39
66176.87
POCF 52.30
MLAB's POCF is ranked lower than
88% of the 99 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.52 vs. MLAB: 52.30 )
Ranked among companies with meaningful POCF only.
MLAB' s POCF Range Over the Past 10 Years
Min: 9.85  Med: 16.41 Max: 53.63
Current: 52.3
9.85
53.63
EV-to-EBIT 32.20
MLAB's EV-to-EBIT is ranked lower than
66% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.32 vs. MLAB: 32.20 )
Ranked among companies with meaningful EV-to-EBIT only.
MLAB' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.4  Med: 12 Max: 34.1
Current: 32.2
5.4
34.1
EV-to-EBITDA 21.45
MLAB's EV-to-EBITDA is ranked lower than
64% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.51 vs. MLAB: 21.45 )
Ranked among companies with meaningful EV-to-EBITDA only.
MLAB' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.9  Med: 10.6 Max: 22.6
Current: 21.45
4.9
22.6
PEG 3.47
MLAB's PEG is ranked lower than
64% of the 61 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. MLAB: 3.47 )
Ranked among companies with meaningful PEG only.
MLAB' s PEG Range Over the Past 10 Years
Min: 0.44  Med: 1.31 Max: 4.51
Current: 3.47
0.44
4.51
Shiller P/E 58.20
MLAB's Shiller P/E is ranked lower than
72% of the 46 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.02 vs. MLAB: 58.20 )
Ranked among companies with meaningful Shiller P/E only.
MLAB' s Shiller P/E Range Over the Past 10 Years
Min: 16.21  Med: 31.05 Max: 59.68
Current: 58.2
16.21
59.68
Current Ratio 1.58
MLAB's Current Ratio is ranked lower than
72% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.44 vs. MLAB: 1.58 )
Ranked among companies with meaningful Current Ratio only.
MLAB' s Current Ratio Range Over the Past 10 Years
Min: 1.44  Med: 11.26 Max: 20.29
Current: 1.58
1.44
20.29
Quick Ratio 0.91
MLAB's Quick Ratio is ranked lower than
78% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. MLAB: 0.91 )
Ranked among companies with meaningful Quick Ratio only.
MLAB' s Quick Ratio Range Over the Past 10 Years
Min: 0.82  Med: 7.94 Max: 16
Current: 0.91
0.82
16
Days Inventory 138.18
MLAB's Days Inventory is ranked lower than
59% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 122.94 vs. MLAB: 138.18 )
Ranked among companies with meaningful Days Inventory only.
MLAB' s Days Inventory Range Over the Past 10 Years
Min: 104  Med: 145.06 Max: 201.41
Current: 138.18
104
201.41
Days Sales Outstanding 54.25
MLAB's Days Sales Outstanding is ranked higher than
65% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.71 vs. MLAB: 54.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
MLAB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.25  Med: 69.47 Max: 81.01
Current: 54.25
54.25
81.01
Days Payable 34.09
MLAB's Days Payable is ranked lower than
72% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.76 vs. MLAB: 34.09 )
Ranked among companies with meaningful Days Payable only.
MLAB' s Days Payable Range Over the Past 10 Years
Min: 9.42  Med: 19.98 Max: 35.03
Current: 34.09
9.42
35.03

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.49
MLAB's Dividend Yield is ranked lower than
80% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. MLAB: 0.49 )
Ranked among companies with meaningful Dividend Yield only.
MLAB' s Dividend Yield Range Over the Past 10 Years
Min: 0.47  Med: 1.33 Max: 2.6
Current: 0.49
0.47
2.6
Dividend Payout 0.22
MLAB's Dividend Payout is ranked higher than
71% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. MLAB: 0.22 )
Ranked among companies with meaningful Dividend Payout only.
MLAB' s Dividend Payout Range Over the Past 10 Years
Min: 0.13  Med: 0.26 Max: 0.35
Current: 0.22
0.13
0.35
Dividend Growth (3y) 5.80
MLAB's Dividend Growth (3y) is ranked lower than
67% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. MLAB: 5.80 )
Ranked among companies with meaningful Dividend Growth (3y) only.
MLAB' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 7.4 Max: 44.2
Current: 5.8
0
44.2
Forward Dividend Yield 0.49
MLAB's Forward Dividend Yield is ranked lower than
84% of the 141 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. MLAB: 0.49 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.67
MLAB's Yield on cost (5-Year) is ranked lower than
80% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. MLAB: 0.67 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MLAB' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.66  Med: 1.87 Max: 3.65
Current: 0.67
0.66
3.65
3-Year Average Share Buyback Ratio -2.40
MLAB's 3-Year Average Share Buyback Ratio is ranked higher than
53% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. MLAB: -2.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MLAB' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.2  Med: -0.8 Max: 6.5
Current: -2.4
-3.2
6.5

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 2.58
MLAB's Price/Projected FCF is ranked lower than
58% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. MLAB: 2.58 )
Ranked among companies with meaningful Price/Projected FCF only.
MLAB' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.51  Med: 1.13 Max: 2.64
Current: 2.58
0.51
2.64
Price/DCF (Earnings Based) 2.67
MLAB's Price/DCF (Earnings Based) is ranked lower than
56% of the 16 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.98 vs. MLAB: 2.67 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.40
MLAB's Price/Median PS Value is ranked lower than
65% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. MLAB: 1.40 )
Ranked among companies with meaningful Price/Median PS Value only.
MLAB' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.48  Med: 0.89 Max: 1.57
Current: 1.4
0.48
1.57
Price/Peter Lynch Fair Value 4.50
MLAB's Price/Peter Lynch Fair Value is ranked lower than
81% of the 37 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.63 vs. MLAB: 4.50 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MLAB' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.46  Med: 1.38 Max: 4.61
Current: 4.5
0.46
4.61
Earnings Yield (Greenblatt) (%) 3.11
MLAB's Earnings Yield (Greenblatt) (%) is ranked higher than
58% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. MLAB: 3.11 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MLAB' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.9  Med: 8.3 Max: 18.7
Current: 3.11
2.9
18.7
Forward Rate of Return (Yacktman) (%) 11.61
MLAB's Forward Rate of Return (Yacktman) (%) is ranked higher than
61% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. MLAB: 11.61 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MLAB' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 10.6  Med: 18.4 Max: 28
Current: 11.61
10.6
28

More Statistics

Revenue (TTM) (Mil) $90.25
EPS (TTM) $ 3.01
Beta0.35
Short Percentage of Float7.72%
52-Week Range $77.00 - 137.20
Shares Outstanding (Mil)3.68
» More Articles for MLAB

Headlines

Articles On GuruFocus.com
Van Den Berg Adds Four Stakes to Portfolio in Second Quarter Jul 14 2015 
Mesa Laboratories Inc. (MLAB) CFO, Secretary Steven W Peterson sells 10,000 Shares Mar 03 2011 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 15 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 16 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 14 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 13 2009 

More From Other Websites
Mesa Laboratories, Inc. – Value Analysis (NASDAQ:MLAB) : December 5, 2016 Dec 05 2016
Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : MLAB-US : December... Dec 02 2016
MESA LABORATORIES INC /CO Financials Nov 16 2016
Mesa’s DryCal Division Releases New FlexCal H Nov 08 2016
Mesa Labs Acquires Hospital-Focused Cold Chain Monitoring Business Nov 07 2016
Mesa Labs Acquires Additional Dental Sterilizer Testing Business Nov 07 2016
MESA LABORATORIES INC /CO Files SEC form 8-K, Other Events Nov 07 2016
Mesa Labs Acquires Hospital-Focused Cold Chain Monitoring Business Nov 07 2016
MESA LABORATORIES INC /CO Files SEC form 10-Q, Quarterly Report Nov 07 2016
ETF’s with exposure to Mesa Laboratories, Inc. : November 4, 2016 Nov 04 2016
MESA LABORATORIES INC /CO Files SEC form 8-K, Other Events Nov 04 2016
Mesa Labs Acquires Additional Dental Sterilizer Testing Business Nov 04 2016
Mesa Laboratories, Inc. :MLAB-US: Earnings Analysis: Q2, 2017 By the Numbers : November 3, 2016 Nov 03 2016
MESA LABORATORIES INC /CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Nov 02 2016
Mesa Labs Reports Record Second Quarter Revenues and Adjusted Net Income Nov 02 2016
Mesa Labs posts 2Q profit Nov 02 2016
Mesa Labs posts 2Q profit Nov 02 2016
Mesa Labs Reports Record Second Quarter Revenues and Adjusted Net Income Nov 02 2016
Insider Buying at 3 Companies Amid Historically Low Insider Buying, Plus Insider Selling at 2... Oct 26 2016
Mesa Labs Declares Quarterly Dividend Oct 04 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)